Interestingly, differential miRNA expression analysis based on PAM50 classification identified larger number of differentially expressed miRNAs compared to HR and HER2 status classification, which suggest better performance of PAM50 in BC subtype stratification. The gene discussed is ERBB2; the disease is breast cancer.